|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$9,064
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$32,092
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$83,133
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$128,488
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$9,570
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$109,001
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$10,311
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$160,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$3,371,242
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$14,744
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S1
|
$34,031
|
$681
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S2
|
$250,000
|
$5,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S3
|
$124,997
|
$2,500
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-07
|
$1,495,000
|
$29,900
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-02
|
$423,409
|
$423,409
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
$6,937
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
$128,917
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
A novel functional genomic pipeline for target identification in sarcoma
|
5R21CA187516-02
|
$165,530
|
$165,530
|
AMATRUDA, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
|
5R01CA151533-05
|
$327,850
|
$81,963
|
AMIN, HESHAM
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Angiogenin-Induced RNA Cleavage in Cancer
|
5R01CA168872-03
|
$357,689
|
$178,845
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$500
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$1,250
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$2,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$1,586
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$72,930
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Manipulation of kinase signaling by the human oncovirus KSHV
|
5F31CA183250-02
|
$35,875
|
$17,938
|
AVEY, DENIS
|
FLORIDA STATE UNIVERSITY
|
|
Development of a New Generation Micro-CT imaging for Functional and Molecular Ima
|
1R01CA196667-01
|
$485,737
|
$485,737
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$374
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$292,561
|
$292,561
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$339,748
|
$339,748
|
Barr, Frederic
|
CCR (NCI)
|
|
Epigenetic studies in rhabdomyosarcoma
|
ZIA BC 011423
|
$311,436
|
$311,436
|
Barr, Frederic
|
CCR (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-02
|
$1,549,280
|
$77,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA042014-26
|
$1,639,000
|
$98,340
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S1
|
$31,248
|
$1,874
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S2
|
$50,000
|
$3,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S3
|
$249,799
|
$14,988
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S4
|
$123,315
|
$7,399
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S5
|
$150,000
|
$9,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S6
|
$178,513
|
$10,711
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma
|
4R00CA178207-03
|
$249,000
|
$124,500
|
BENAVENTE ARIAS, CLAUDIA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,372,042
|
$23,720
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$189,189
|
$18,919
|
Beutler, John
|
CCR (NCI)
|
|
JHU ICMIC Program
|
5P50CA103175-10
|
$1,485,716
|
$178,286
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
Improving etoposide treatment of Ewing's sarcoma
|
5R01CA152063-05
|
$309,653
|
$309,653
|
BISHOP, ALEXANDER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Innate anti-tumor immune responses
|
3R01CA157885-05S1
|
$66,507
|
$19,952
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Innate anti-tumor immune responses
|
5R01CA157885-05
|
$311,289
|
$93,387
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
Total relevant funding to Sarcoma for this search: $71,304,593
|